Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Serneels L, Van Biervliet J, Craessaerts K, Dejaegere T, Horré K, Van Houtvin T, Esselmann H, Paul S, Schäfer MK, Berezovska O, Hyman BT, Sprangers B, Sciot R, Moons L, Jucker M, Yang Z, May PC, Karran E, Wiltfang J, D'Hooge R, De Strooper B. gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science. 2009 May 1;324(5927):639-42. PubMed Abstract, View on AlzSWAN

  
Comments on Paper and Primary News
  Comment by:  Michael Wolfe, ARF Advisor
Submitted 6 January 2010  |  Permalink Posted 6 January 2010

This paper describes the role of the different Aph1 subtypes in the production of Aβ and in Notch-related toxicities. The evidence suggests that Aph1B-containing γ-secretase complexes would be worthwhile targets, if one could selectively hit this type of γ- secretase complex and not Aph1A-containing complexes. Aph1B- containing complexes clearly play the major role in Aβ production in the brain and do not contribute much to Notch signaling, at least in mice. This can be fully explained by differential tissue expression between Aph1A and B, though, and not by biochemical differences, as suggested by the authors. Aph1B-containing complexes may be a very worthwhile target, if there are any biochemical differences that can be exploited by small molecule inhibitors (which remains to be seen).

View all comments by Michael Wolfe
Comments on Related News
  Related News: Perpetrator and Savior—Presenilins Cut Both Ways

Comment by:  Ilya Bezprozvanny
Submitted 5 June 2009  |  Permalink Posted 5 June 2009

The paper by Tabuchi at al. is a fascinating study that uses genetic approach to investigate the importance of γ-secretase activity for neuronal survival. The authors generated floxed nicastrin mice and crossed them with the α-CaMKII-Cre transgenic driver line that expresses Cre recombinase specifically in the excitatory neurons of postnatal forebrain. The resulting nicastrin cKO mouse line appears to be essentially normal at two months of age. By the age of six and nine months, nicastrin cKO mice developed age-dependent memory deficits, displaying apoptotic loss of cortical neurons and active gliosis. The phenotype of aging nicastrin cKO mice is very similar to the phenotype of presenilin cDKO mice that Jie Shen’s group previously described (1). The authors conclude that 1) γ-secretase activity is essential for neuronal survival; and that 2) γ-secretase independent functions of presenilins, such as ER Ca2+ leak function (2), are not important for neuronal survival in this context.

The experimental design is very elegant and leaves no doubt that γ-secretase function is...  Read more


  Related News: Perpetrator and Savior—Presenilins Cut Both Ways

Comment by:  Taisuke Tomita
Submitted 10 June 2009  |  Permalink Posted 10 June 2009

In this paper, Tabuchi et al. report a novel mouse that specifically lacks the nicastrin gene in excitatory neurons. Nicastrin cKO mice showed memory impairment and age-dependent cortical neuron loss, similar phenotypes to the PS cDKO mice. Of note, the nicastrin cKO mice showed significant memory impairment at two months of age. At this stage, the gross brain morphology was normal, suggesting that “functional” defects would have already occurred by the deletion of nicastrin gene, presumably the complete loss of γ-secretase activity in neurons. These data implicate that the neuronal γ-substrate is functionally important in learning and memory without significant synaptic loss or neuron death. Thus, unveiling the molecular mechanism whereby the cKO neurons showed functional defects is an important issue to consider the physiological role of the γ-secretase activity in the brain.

View all comments by Taisuke Tomita

  Related News: Perpetrator and Savior—Presenilins Cut Both Ways

Comment by:  Philippe Marambaud
Submitted 10 June 2009  |  Permalink Posted 10 June 2009

I think this is a very elegant study that reveals the fundamental role of nicastrin in neuronal integrity and memory in adult mice. This work also confirms in vivo, in the adult brain, that nicastrin is essential for the stabilization and activity of the γ-secretase complex. These results are nicely in line with the notion that complete or partial loss of function of presenilins is, per se, neurotoxic.

The challenge will be now to determine what are the signaling pathways—downstream from γ-secretase—involved in neuronal death in the aging brain. Cadherins may represent attractive candidates. Indeed, the cadherin family of cell-cell adhesion proteins is abundantly expressed at mature synapses, is critical for synaptic plasticity, and is cleaved by γ-secretase in neurons upon NMDA receptor stimulation (Marambaud et al., 2003). It is, therefore, reasonable to think that a loss of synaptic cadherin cleavage by γ-secretase may lead over time to defects in synaptic plasticity and neuronal integrity and thus may contribute to the phenotype observed in these mice.

Another...  Read more


  Related News: Perpetrator and Savior—Presenilins Cut Both Ways

Comment by:  Bart De Strooper, ARF Advisor
Submitted 11 June 2009  |  Permalink Posted 11 June 2009

This is a very elegant knockout study reinforcing previous work of Jie Shen published in Neuron, which showed that presenilin 1 and 2 double deficient mice display a progressive neurodegenerative disorder.

In contrast with their previous paper in Neuron, Shen and colleagues now conclude that the neurodegeneration they see in both PS1 and 2 double KO mice, and nicastrin single KO mice is due to a γ-secretase defect, i.e., the loss of proteolytic function. This is part of an ongoing debate as to what extent postulated functions of presenilin outside the γ-secretase complex contribute to the overall phenotype of presenilin deficient mice. While I tend to believe that the neurodegeneration observed in their studies is indeed reflecting a real γ-secretase defect, the current paper is not conclusive in that regard. Indeed, knockout of nicastrin also destabilizes presenilin, and could theoretically affect functions of presenilin independent of its proteolytic function. However, I agree with Shen and colleagues that their current interpretation is the most likely one, as the major...  Read more

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
The following antibodies were used in this paper:
Semi-quantitative immune blot analysis using anti-FLAG (M2) (Sigma); Aβ peptides were analyzed by urea-based Aβ SDS-PAGE and immune blot using 82E1 (Demeditec Diagnostics), a monoclonal mouse antibody specific for the N-terminus of Aβ or 1E8, another N-terminus specific monoclonal antibody (Dr. T. Dyrks, Bayer Schering Pharma AG).
ELISAx-40(the Genetics Company) and ELISA1-42 (Biosource) were performed according the manufacturer’s recommendations.
FLIM: Cells were immunostained with antibodies directed against the PS1 amino-terminus (NTF) alone (for the negative control) or antibodies against PS1 NTF and carboxyl-terminus (CTF) using goat anti-NTF (Sigma), and rabbit anti-CTF, (Sigma), respectively, or against PS1 NTF and a monoclonal antibody directed against the transmembrane domain 6-7 loop (Millipore).
Mouse brain homogenates were centrifuged at 4°C for 1 hr at 100,000 x g and the supernatants used for ELISA (the Genetics Company) and SDSPAGE immune blot (Invitrogen). Total protein concentrations were determined using the BCA protein assay (Pierce) and were used to determine the amount to load for SDS-PAGE, ELISA, or AlphaSreen assays. Antibodies used include monoclonal mouse 6E10 against Aβ1-17, (Sigma), WO2 against Aβ5-8, (the Genetics Company), 22C11 against APP66-81, (Chemicon), a polyclonal APP C-terminal antibody (in-house) and anti β-actin (Sigma).
Endogenous mouse Aβx-40 and Aβx-42 from 5 M guanidine-HCl brain extracts were measured by ELISAs re-configured in order to measure endogenous murine Aβ by using C-terminal specific capture antibodies 2G3for Aβ40, and 21F12 for Aβ42 and biotinylated m266 as the detection antibody.
Notch related side effects: Peripheral blood lymphocytes and single cell suspensions were labeled with FITC-, PE- or PerCP-conjugated antibodies directed against CD3, CD4, CD8, CD25, CD62L, B220, IgM, IgD, CD23, CD21, DX5 and NK1.1 (Pharmingen, Becton Dickinson; eBioscience, ImmunoSource and Caltag Laboratories)

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad